| |
IMS Health Second Quarter Results
IMS Health has reported diluted earnings per share from recurring operations of $0.23 for the quarter ended June 30, 2002, up 5 percent from last year's second quarter. Net income from recurring operations was $66.0 million, essentially unchanged year over year.
During the second quarter, revenue totalled $353.0 million, up 5 percent constant dollar year over year and 6 percent on a reported basis. Operating income was $105.0 million, down 2 percent on a reported and constant-dollar basis from the year-earlier quarter. Net income of $66.0 million was essentially unchanged from the same period last year.
IMS's first-half 2002 revenue rose to $684.4 million, up 5 percent constant dollar and 3 percent on a reported basis. This compares with revenue of $663.9 million in the 2001 first half. Operating income for the first six months of 2002 was $196.3 million, down 4 percent on a reported basis and unchanged on a constant-dollar basis from the year-earlier period. Net income rose 2 percent to $124.8 million, or $0.43 per share, compared with $122.2 million, or $0.41 per share, in the first half of 2001.
'IMS delivered a solid performance in the second quarter within a challenging pharmaceutical environment,' said David Thomas, IMS chairman, chief executive officer and president. 'We continue to see the results of our enhanced customer focus -- offering new product innovations and strengthening our consulting capabilities.'
|
